GoKawiilBridge Neurotech launches with $13.5M to build non-surgical brain-computer interface
Bridge Neurotech has emerged from stealth with $13.5 million in funding, including backing from General Catalyst, to develop a wearable, ultrasound-based brain-computer interface. Founder and CEO Will Biederman, who previously developed chip technology licensed by Neuralink, says his goal is to avoid the surgical implants used by competitors like Neuralink, Synchron, Paradromics and Precision Neuroscience.
GoKawiil's interpretation of the reporting above, not reported fact.
The entry of another well-funded startup suggests investors see a viable market for non-invasive brain-computer interfaces that could reach far more users than surgical implants, which Biederman notes have only been used in about 100 people worldwide. However, wearable approaches have historically struggled with weaker signal quality due to bone and skin interference, so Bridge's ultrasound method would need to overcome that technical hurdle to compete with implant-based rivals like Merge Labs and Neuralink.
- Bridge Neurotech raised $13.5 million, including investment from General Catalyst, to build a non-surgical brain-computer interface.
- CEO Will Biederman previously developed chip technology that Neuralink licensed for its devices.
- The company aims to use ultrasound to overcome signal-quality limitations that have hindered other wearable brain-computer interfaces.
Source: wired.com, 2026-10-06
Published there as: “A New Neurotech Startup Launches to Rival Sam Altman’s Merge Labs”
Read the original report → The summary and analysis above are GoKawiil's own, written from reporting by the source above. Facts and quotes belong to the original publisher.